Company Filing History:
1 out of 12,160 
1 out of 378 
Years Active: 2023
Title: Marie Glatz: Innovator in MASP Inhibitory Compounds
Introduction
Marie Glatz is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on MASP inhibitory compounds. Her research focuses on the development of novel compounds that can be utilized in the treatment and prevention of various diseases.
Latest Patents
Marie Glatz holds one patent titled "MASP inhibitory compounds and uses thereof." This invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory compounds, as well as analogues and derivatives thereof. The patent outlines processes for the preparation of these compounds and their applications in treating and preventing diseases, especially renal and cardiovascular disorders, as well as ischemia-reperfusion injuries.
Career Highlights
Throughout her career, Marie has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Marie has collaborated with esteemed colleagues, including Donald Bierer and Ingo Flamme. These partnerships have further enriched her research and innovation in the field.
Conclusion
Marie Glatz is a pioneering inventor whose work on MASP inhibitory compounds has the potential to impact the treatment of critical health conditions. Her contributions to medicinal chemistry exemplify the importance of innovation in healthcare.